Participated · Seed · Aug 2026

AGent Energy uses an AI-based platform to aggregate, orchestrate, and monetize distributed generation assets at commercial, industrial, and mission-critical facilities. The platform turns existing behind-the-meter backup generation into rapidly dispatchable capacity that can be bid into wholesale markets, with no cost to the asset owner and new revenue earned by owners. AGent reports it is already dispatching and has delivered capacity in three major North American wholesale markets: PJM, MISO, and ERCOT. Financially, the company has raised $17 million in its first 12 months, including an $11 million Series Seed co-led by Spero Ventures and MassMutual Ventures. AGent plans to use the capital to aggressively scale its team and pursue a target of unlocking over 200 GW of behind-the-meter generation across commercial, industrial, and MUSH sectors. The company emphasizes rapid deployment and reliability benefits versus new-build capacity as core differentiators.

Led · Series B · Apr 2025

Skin Analytics develops DERM, an AI medical device that the company says is the world’s first legally authorised system able to independently make clinical decisions on skin cancer following EU MDR Class III CE mark approval. DERM was trained on a very large image dataset including skin cancers, pre‑malignant conditions and benign mimics, and provides triage recommendations to reserve dermatology capacity for patients in greatest need. The company reports DERM can autonomously discharge up to 40% of urgent suspected skin cancer referrals and rules out the most high‑risk skin cancers 99.8% of the time versus 98.9% for dermatologists. NHS Trusts using DERM have reduced unnecessary face‑to‑face dermatology appointments by up to 95%, and the device has been deployed at 26 NHS sites, used in pathways serving more than 150,000 patients and detecting over 14,000 cancers. The firm plans to expand its product scope to cover all dermatology concerns, grow internationally into Europe and Australia, and accelerate entry into the US. It is also recruiting AI and healthcare talent to scale its offerings and operations. Skin Analytics offers a CE-marked medical device and a clinically validated AI system that the company says can identify skin cancers, pre-cancerous and benign lesions at a level comparable to a dermatologist. The system uses a low-cost attachment and a smartphone to enable deployment in GP practices and hospitals, aiming to reduce the diagnostic burden on dermatologists. The company launched an AI-powered clinical pathway with University Hospital Birmingham and continues to forge partnerships within the U.K. National Health Service. Skin Analytics says its service can reduce the number of patients who end up in hospital by 40–60%, depending on where the technology is used. It recently raised £4 million in a Series A and plans to use the funding to expand its focus to the U.S., supported by an FDA Breakthrough Device Designation to fast-track the technology. Founder Neil Daly emphasizes the firm’s reliance on prospective clinical studies and regulatory processes as key differentiators in a crowded AI skin-cancer field.

Participated · Series B · Oct 2024

Andium builds an end-to-end Industrial Internet of Things (IIoT) platform for remote-field monitoring and communications, focused on delivering real-time, verifiable emissions data and ESG monitoring. The solution is designed to help customers reduce emissions, improve safety, and boost operational efficiency. Led by CEO and Founder Jory Schwach, the company targets consequential markets, notably oil and gas basins. Andium plans to use new funding to accelerate global expansion and scale operations across U.S. and Middle Eastern oil and gas basins. Financially, the company has raised more than $40M to date, including a $15M Series A in 2021 and the recent Series B. The platform and strategy emphasize data-driven operational and environmental improvements for industrial customers. Andium builds Industrial IoT remote-field monitoring and communications solutions using a novel end-to-end operating system that delivers verifiable, real-time information from remote oil-and-gas locations at a fraction of the cost of other solutions. Its product suite includes proprietary Video Solutions for flare monitoring, tank telemetry, and object detection. The company emphasizes lowering the barrier to entry for operators by offering lower-cost, flexible monitoring that supports ESG and emissions-reduction goals. Andium says its technology turns monitoring into an automated, digital process to improve operational efficiency and sustainability outcomes. The new capital will be used to drive product growth and innovation, invest in talent, and accelerate deployment of its Video Solutions lines. Andium framed the funding as enabling partners to decarbonize through digitalization while delivering strong returns via operational efficiencies.

Participated · Series A · Feb 2023

Aquafortus is an Auckland, New Zealand–based water technology company led by CEO Daryl Briggs. It develops and commercializes novel, proprietary minimal-energy resource recovery technologies for dissolved solids (TDS) waste and process streams. The company employs a non-thermal, zero-liquid-discharge recovery and crystallization approach that uses 90% less energy, costs 60% less, and converts 98% of high-salinity brine into fresh water while extracting lithium, copper, magnesium salts, and other metals and minerals. Aquafortus targets industries that produce significant volumes of hypersaline water, including mining, oil and gas production, chemical manufacturing, and power generation. The company raised $17M in Series A1 funding to support commercialization efforts. Proceeds will fund construction and deployment of a relocatable demonstration unit and a commercial pilot across major U.S. oil and gas basins and operators, and will be invested in core R&D.